Inogen | INGN - Current Assets


Inogen reported $203.72M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 357.52M 566K Mar/2026
AtriCure USD 313.69M 8.82M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Chart Industries USD 2.86B 39.7M Mar/2026
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.71B 204.5M Mar/2026
Masimo USD 870.5M 55.5M Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Philips EUR 9.78B 148M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Steris USD 2.39B 108.4M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
X T L Biopharmaceuticals USD 533K 807K Jun/2025
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026